Operator
Hello, and welcome to the Kulicke and Soffa 2021 Second Fiscal Quarter Results Conference Call and Webcast. [Operator Instructions]
It s now my pleasure to turn the call over to Joe Elgindy, Senior Director, Investor Relations and Strategic Initiatives. Joe, please go ahead.
Joseph Elgindy
Director of Investor Relations & Strategic Planning
Thank you. Welcome, everyone, to Kulicke and Soffa s Fiscal Second Quarter 2021 Conference Call. Joining us on today s call is Fusen Chen, President and Chief Executive Officer; and Lester Wong, Chief Financial Officer. For those of you who have not received a copy of today s results, the release as well as the supplemental earnings presentation are both available in the Investor Relations section of our website at investor.kns.com. In addition to historical statements, today s remarks will contain statements relating to future events and our future results. These statements are forward-looking statements within the meaning of the
Operator
Good day and thank you for standing by. Welcome to the Q1 2021 Editas Medicine Earnings Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions]
I would now like to hand the conference over to your first speaker today, Ron Moldaver, Investor Relations. Please go ahead.
Ron Moldaver
Investor Relations
Thank you, Julian. Good morning, everyone, and welcome to our first quarter 2021 conference call. Earlier this morning, we issued a press release providing our financial results and corporate updates for the first quarter of 2021. A replay of today s call will be available on the Investors section of our website approximately 2 hours after its completion. After our prepared remarks, we will open the call for Q&A.